Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Stuttgart - Delayed Quote EUR

PTC Therapeutics Inc (BH3.SG)

Compare
38.80
+1.80
+(4.86%)
At close: April 15 at 8:00:52 AM GMT+2
Loading Chart for BH3.SG
  • Previous Close 37.00
  • Open 38.80
  • Bid 41.00 x --
  • Ask 42.20 x --
  • Day's Range 38.80 - 38.80
  • 52 Week Range 22.40 - 52.00
  • Volume 0
  • Avg. Volume 1
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Apr 23, 2025 - Apr 28, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: BH3.SG

View More

Performance Overview: BH3.SG

Trailing total returns as of 4/15/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

BH3.SG
8.49%
S&P 500 (^GSPC)
8.25%

1-Year Return

BH3.SG
63.03%
S&P 500 (^GSPC)
6.61%

3-Year Return

BH3.SG
4.43%
S&P 500 (^GSPC)
22.86%

5-Year Return

BH3.SG
7.62%
S&P 500 (^GSPC)
93.89%

Compare To: BH3.SG

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BH3.SG

View More

Valuation Measures

Annual
As of 4/14/2025
  • Market Cap

    3.13B

  • Enterprise Value

    4.31B

  • Trailing P/E

    --

  • Forward P/E

    15.70

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.00

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    6.06

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: BH3.SG

View More

Company Insights: BH3.SG

Research Reports: BH3.SG

View More